Bamett, H.L. , McNamara, H., Schultz, S. and Tompsett, R.: Renal clearances of sodium penicillin G, procaine penicillin G and inulin in infants and children. Pediatrics3: 418, 1949.
2.
Brown, A.K. and Zuelzer, W.W.: Studies on the eonatal development of the glucuronide conjugating system. J. Clin. Invest.37: 332, 1958.
3.
Burns, L. and Hodgman, J.E.: Studies of prematures given erythromycin estolate. Amer. J. Dis. Child.106: 280,1963.
4.
Cohlan, S.Q. , Bevelander, G. and Tiamsil, T.: Growth inhibition of prematures receiving tetracycline. Amer. J. Dis. Child.105: 453, 1963 .
5.
Crawford, J.D. , Terry, M.E. and Rourke, G.M.: Simplification of drug dosage calculation by application of the surface area principle. Pediatrics5: 783. 1950.
6.
Doell, R.G. and Kretchmer, N.: Studies of small intestine during development. Biochem. Biophys. Acta62: 353, 1962.
7.
Driscoll, S.G. and Hsia, D.Y.-Y.: The development of enzyme systems during early infancy. Pediatrics22: 785, 1958.
8.
Eichenwaid, H.F. and Shinefield, H.R.: Antimicrobial therapy in the neonatal period . Pediat. Clin. N. Am.8: 509, 1961.
9.
Fouts, J.R. and Adamson, R.H.: Drug metabolism in the newborn rabbit. Science129: 897, 1959.
10.
Hodgman, J.E. and Burns, L.E.: Safe and effective chloramphenicol dosages for premature infants. Amer. J. Dis. Child.101: 140, 1959.
11.
Hunt, A.D., Jr. and Fell, M.B.: Streptomycin intramuscular dosage per unit body weight correlated with serum levels in infants and children. Pediatrics4: 163, 1949.
12.
Joudorf. W.R. , Maickel, R.P. and Brodie, B.B.: Inability of newborn mice and guinea pigs to metabolized rugs. Biochem. Pharmacol.1: 352, 1958-59.
13.
Kretchmer, N.: Enzymatic patterns during development. An approach to a biochemical definition of immaturity. Pediatrics23: 606, 1959.
14.
Levin, B. and Neill, C.A.: Oral penicillin in the newborn. Arch. Dis. Child.24: 171, 1949.
15.
Lokietz, H. , Dowben, R.M. and Hsia, D.Y.: Studies on the effect of novobiocin on glucuronyl transferase. Pediatrics32: 47, 1963.
16.
Nyhan, W.L. : Toxicity of drugs in the neonatal period. J. Pediat.59: 1, 1961.
17.
Odell, G.B. : Studies in kernicterus. I. The protein binding of bilirulxin. J. Clin. Invest.38: 823, 1959.
18.
Percy, A.K. and Yaffe, S.J.: Sulfate metabolism during mammalian development . Pediatrics33: 965, 1964.
19.
Silverman, W.A., Andersen, D.H., Blanc, W.A. and Crozier, D.N.: A difference in mortality rate and incidence of kernicterus among premature infants allocated to two prophylactic antibacterial regimens. Pediatrics18: 614, 1956.
20.
Sutherland, J.M. and Mohlman, Y.M.: Antimicrobial therapy in the newborn infant . Pediat. Clin. N. Am.8: 1143, 1961.
21.
Teixeira, G.C. and Scott, R.B.: Further clinical and laboratory studies with novobiocin. Antibiot. Med.5: 577, 1958.
22.
Weiss, C.F. , Glazko, A.J. and Weston, J.K.: Chloramphenicol in the newborn infant. New Eng. J. Med.262: 787, 1960.
23.
Ziegra, S.R. and Storm, B.A.: Dosage of chloramphenicol in premature infants. J. Pediat.58: 852, 1961.
